To further explore the molecular mechanism of TPRA1‐mediated OVM entry, we used Arbidol, a clathrin‐dependent endocytosis inhibitor, and found that Arbidol can partially inhibit the infection of OVM, suggesting TPRA1‐mediated entry via the clathrin pathway (Figure S8, Supporting Information). This evidence concerns the gene TPRA1 and infection.